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Abstract
Background: Endogenous reference genes are commonly used to normalize expression levels of
other genes with the assumption that the expression of the former is constant in different tissues
and in different physiopathological conditions. Whether this assumption is correct it is, however,
still matter of debate. In this study, we searched for stably expressed genes in 384 cDNA array
hybridization experiments encompassing different tissues and cell lines.
Results: Several genes were identified whose expression was highly stable across all samples
studied. The usefulness of 8 genes among them was tested by normalizing the relative gene
expression against test genes whose expression pattern was known. The range of accuracy of
individual endogenous reference genes was wide whereas consistent information could be obtained
when information pooled from different endogenous reference genes was used.
Conclusions: This study suggests that even when the most stably expressed genes in array
experiments are used as endogenous reference, significant variation in test gene expression
estimates may occur and the best normalization is achieved when data from several endogenous
reference genes are pooled together to minimize minimal but significant variation among samples.
We are presently optimizing strategies for the preparation of endogenous reference gene mixtures
that could yield information comparable to that of data pooled from individual endogenous
reference gene normalizations.
Background
Endogenous reference alse referred to as house keeping
genes defines in biology the theoretical assumption that
certain genes are ubiquitously expressed in nucleated cells
possibly because their stable expression is essential for cell
survival and welfare in all physio-pathological
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circumstances. In practical terms, endogenous reference
genes provide a useful constant reference to normalize the
expression of test genes in different tissues and in different
conditions. This is obviously important when estimates of
gene expression are provided in relative terms rather than
absolute units of measurement. Thus, endogenous refer-
ence genes are used as common denominator in biologi-
cal fractions where the expression of a test gene is
described as the relative ratio over an arbitrarily selected
internal control presumed to be stably expressed in all cir-
cumstances relevant to the experiment [1-3]. Most fre-
quently, glyceraldehydes-3-phosphate dehydrogenase
(GAPDH) [4,5], albumin (for hepatocytes) [6], β-, γ-actins
[7,8], cyclophilin [9,10], α-, β-tubulins [7,11], hypoxan-
tine phosphoribosyltransferase (HRPT) [12,13], L32
[14,15] and 18S, 28S ribosomal RNA (rRNA) [16-18]
have been used as endogenous reference genes. Depend-
ing upon the experimental design, endogenous reference
genes have been used individually or in combination for
Northern blot analysis, reverse transcription polymerase
chain reaction (RT-PCR) and quantitative real-time PCR
(qRT-PCR) analysis [19,20]. With the development cDNA
microarray technology endogenous reference genes have
been used for array data normalization. However, accu-
mulation of extensive data bases suggests that the expres-
sion of frequently used endogenous reference genes can
vary substantially according to materials and conditions
studied [1,2,6,14,17,18,20-27].
Powerful insights in patterns of gene expression could be
attained recently through cDNA or oligonucleotide-based
global transcript analysis tools that apply a constant refer-
ence system to determine ratios of gene expression across
large data sets [28,29]. The constant reference is provided
for each gene in question by consistently co-hybridizing
individual test samples with a differentially labeled refer-
ence sample maintained identical throughout all the
hybridization experiments. Gene expression data are then
expressed as the ratio of expression between test and ref-
erence samples for each gene. By keeping the reference
sample identical the resulting ratio represents a precise
estimate of the relative expression of each gene across the
various conditions tested bypassing the need to normalize
with endogenous reference genes. This holds true if the
hybridization kinetics between test and reference sample
are accurately reproducible. We will refer to this concept
as "reference concordance" and in the results we will dis-
cuss how reference concordance was used to validate the
reproducibility of cDNA array data from which putative
candidate endogenous reference genes were identified.
In the present study, we tested a set of 419 consecutive
experiments performed on a 17,000 gene cDNA array
platform to which RNA from neoplastic or normal tissues
were consistently co-hybridized with a differentially-
labeled reference RNA derived from peripheral blood
mononuclear cells (PBMC) pooled from six normal
donors. The following steps were pursued: 1) Reproduci-
bility assessment of the data set through determination of
reference concordance. This was achieved by repeating 14
reference experiments using the melanoma cell line A375
as test sample (Cy5) co-hybridized with pooled PBMC as
reference (Cy3). To test for inter-array and printing varia-
tion, slide number one and every other 25 slides in
sequential order of printing (100 slides per printing set)
were used for the repetitive A375 / pooled PBMC hybrid-
izations. In addition, to assess labeling bias, reciprocal
labeling was alternatively applied as previously described
[30]. In this fashion a pool of genes expressed with high
level of reference concordance was selected. 2) Identifica-
tion of putative endogenous reference genes was per-
formed on 384 array experiments of unequivocal quality
by selecting genes that had demonstrated high reference
concordance (>90% of the genes in the arrays) and rank-
ing them from the lowest to the highest variance of Log2
test / reference ratios across all array experiments. 3) Vali-
dation of the candidate endogenous reference genes as
predictor of relative gene expression in large data series.
For this purpose, we tested the relative estimates of expres-
sion of the melanocytic lineage-restricted melanoma dif-
ferentiation antigen gp100/Pmel17 (gp100) [31] in
melanocytic and non-melanocytic tissues. Estimates of
expression of gp100 were compared after normalization
with different endogenous reference genes. For this analy-
sis, we used a new tool that spots cDNA libraries from dif-
ferent tissues on an array platform to allow high-
throughput evaluation of individual gene expression
across broad tissue collections. We termed this tool: "tran-
scriptome array". 4) Validation of endogenous reference




The GenePix Pro 4.0 software was used for array image
analysis and calibration. All statistical analyses were per-
formed with the SPLUS package http://www.insight
ful.com. Thirteen arrays with missing data in more than
30% of the spots and 8 arrays with irregular distribution
according to M-A plots (M and A representing respectively
log-ratios and average intensities) [32] were excluded.
Spots in which > 50% of the pixels reached saturation in
either channel, flagged spots and spots with intensity ≤
200 in one channel and ≤ 500 in the other channel were
filtered out. If the intensity in one channel was < 200 but
that of the other channel was > 500, we arbitrarily
assigned an intensity of 200 to the channel with the low-
est intensity. The log2Cy5/Cy3 ratios were normalized by
approximating median values to zero. Spots with ratios >
100 or < 1/100 were truncated at 100 and 1/100BMC Genomics 2004, 5:55 http://www.biomedcentral.com/1471-2164/5/55
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respectively. Data normalization was done by median
centering Log2ratio of all genes for each array. For data nor-
malization we used certain arbitrary cutoff criteria to
remove spots with weak signal. Weak signal approximat-
ing background fluorescence is not reliable and the corre-
sponding log ratios are often distorted resulting in
disproportionately high or low values that would bias the
statistical results. Because the interpretation of spots with
low signal is difficult to make we have adopted the policy
of excluding them to focus the analysis on genes whose
expression pattern is more reliably tracked by the array
tool. In regard to spots with a ratio of >100 or <-1/100,
most of them are due to extremely weak signal in one
channel which generates a disproportionately extreme
value. Although there is no published "gold standard" for
the selection of such cutoffs, in practice the parameters
that we used for this study are most commonly accepted
by investigators and reasonable because allow retention
of most of the data in the array excluding only the most
extreme and least reliable information.
Validation of the data set through analysis of "reference 
concordance"
To select from the data base the most reliable genes, we
first assessed reproducibility by testing the level of con-
cordance in 14 reference experiments. Reference concord-
ance relies on the expectation that results obtained by
repeatedly hybridizing the same test and reference mate-
rial should perfectly collimate and the degree of deviation
from such prediction estimates experimental variance.
Concordance can be easily measured by periodically re-
hybridizing the same test sample with the constant refer-
ence sample. We analyzed a matrix of 7 forward and 7
reciprocally-labeled replicate array experiments hybrid-
ized periodically every other 25 cDNA array slides. Recip-
rocal labeling was applied to measure labeling bias [30].
Data generated by reciprocal experiments were mathemat-
ically reversed into the same labeling direction for data
analysis. Genes that were discordant due to labeling bias
were identified by student's t test as those with ratios sig-
nificantly different between the 7 forward and 7 reciprocal
experiments after reversal of the reciprocal values (P <
0.05) and the median ratio difference between the 7 for-
ward and 7 reciprocal experiments was larger than 1.5
fold. The genes whose variances of the log ratio across all
experiments were among the top 1 percentile of variance
of all genes were identified as discordant due to hybridi-
zation bias. In addition, genes with more than 50% miss-
ing values were excluded. Overall 1,343 out of 16,738
were judged potentially discordant and were excluded
from further analysis. The remaining 15,395 concordant
genes were used for subsequent analyses.
Endogenous reference gene identification
We studied 384 of 419 consecutive array experiments
remaining after the exclusion of the 14 reference concord-
ance experiments and 21 experiments judged of poor
quality due to missing data or irregular distribution by M-
A plot analysis. Selection of candidate endogenous refer-
ence genes followed these steps.
First, the seven experiments used for the analysis of refer-
ence concordance in which labeling was done identically
to the rest of the experimental samples (test labeled with
Cy5 and reference with Cy3) were used to calculate exper-
imental variance (Table 1). Median of variances across the
seven replicate arrays was calculated for all genes with
average intensity in both channels > 2,000. This parame-
ter provides an estimate of the variance due to experimen-
tal variation (background variance) since theoretically no
differences in gene expression should be noted by using
the same material. Based on the assessment of the seven
repeat experiments, we defined differential expression as
> 2 standard deviations (SD) from the mean of the 384
arrays which is equivalent to 1.46-fold change (± 0.549 in
log2 ratio). Consequently, genes with fold changes < 1.46
from zero across all 384 arrays were categorized as candi-
date endogenous reference genes and were ranked accord-
ing to ascending values of SD of Log ratio (Table 1).
Among these genes, we further selected candidate endog-
enous reference genes according to the following criteria:
in at least 95% of the 384 arrays the Log2 ratio had to be
within 2 SD from zero and the average intensities of both
channels across all samples need to be higher than 2,000.
The intensity parameter was added to ensure that the
selected endogenous reference genes were expressed at a
relatively high level in most tissues to mitigate excessive
fluctuations in Log2 ratios occurring when a low value is
applied as denominator. This is important when a refer-
ence gene is applied as a denominator in the equation
used to normalize the ratio of other tests genes; in such
cases robust gene expression decreases the range of ratios
resulting from the analysis decreasing, therefore, the
experimental variance. Sixty-nine genes fit these criteria.
The range of mean Log2 ratio was from 0 to 0.15 and the SD
of mean Log2 ratio was from 0.27 to 0.42. Analysis of 7 rep-
licate array based on the same group of candidate endog-
enous reference genes demonstrated a similar distribution
of mean Log2 ratio and SD of mean Log2 ratios (with excep-
tion of TFAP2B) suggesting that this variance could be
attributed to predominantly experimental noise. Among
these genes we further selected for validation 11 that had
high mean fluorescence intensity (underlined in Table 1).
However, probe preparation and other technical consider-
ations limited to analysis to only 8 of these genes which
included: NEED8, HIRIP5, GPLD1, RAB31, SNRPD3,
FZD6, COL8A1 and AFAP.BMC Genomics 2004, 5:55 http://www.biomedcentral.com/1471-2164/5/55
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Table 1
384 experiments 7 replicates










cDNA FLJ40458 1571492 Hs.181346 2835 0.19 0.27 0.39 0.15
Unknown 301067 2571 0.1 0.27 0 0.21
PTH 322051 Hs.37045 3380 0 0.28 -0.02 0.27
KIAA1935 39938 Hs.300776 2359 0.16 0.28 0.01 0.19
ESTs 49313 Hs.395460 2079 0.15 0.28 0.08 0.03
cDNA FLJ30539 fis 49463 Hs.21489 2561 0.09 0.28 0.17 0.13
SDCCAG16 1576228 Hs.271926 2111 0.11 0.29 0.28 0.14
clone IMAGE:41799 278673 Hs.271721 3132 0.16 0.3 -0.04 0.1
PSIP2 289945 Hs.82110 2521 -0.07 0.3 -0.06 0.19
ETV2 1468722 Hs.194061 2646 0.09 0.31 0 0.28
ESTs 1571401 Hs.126999 2659 0.05 0.31 -0.04 0.08
NEDD8 277660 Hs.75512 3875 0.08 0.31 0.1 0.2
HIP2 486259 Hs.155485 2511 0.11 0.31 0.12 0.25
HIRIP5 745314 Hs.430439 3407 -0.08 0.31 0.07 0.31
ACTR8 156363 Hs.124219 2731 0.08 0.32 0.14 0.16
GPLD1 293696 Hs.272529 3110 -0.03 0.32 -0.05 0.28
KIAA0769 299128 Hs.19056 2148 0.14 0.32 0.05 0.2
CSNK1G2 346031 Hs.181390 2320 -0.03 0.32 -0.24 0.28
RAB31 784150 Hs.223025 3479 -0.06 0.32 -0.36 0.36
C14orf117 796100 Hs.103189 2008 0.12 0.32 -0.01 0.16
ATP6IP2 825077 Hs.183434 2159 0.02 0.32 0.28 0.32
SNRPD3 897099 Hs.1575 3031 -0.04 0.32 -0.48 0.25
Unknown 1292073 2745 -0.13 0.33 0.05 0.28
ESTs 22137 Hs.187406 3133 0.07 0.33 -0.01 0.21
ESTs 32782 Hs.443140 2464 -0.02 0.33 0.09 0.26
L3MBTL 43090 Hs.300863 2581 -0.08 0.33 -0.41 0.31
GNRH1 487071 Hs.82963 3294 0.05 0.33 0.23 0.23
clone 24629 mRNA 746258 Hs.142570 2645 0.05 0.33 -0.21 0.14
FLJ12998 826367 Hs.343627 2267 0.14 0.33 0.03 0.3
cDNA: FLJ23477 fis 1492329 Hs.145362 2142 0.09 0.34 0.35 0.34
HOXC4 1756945 Hs.50895 2581 0.03 0.34 -0.02 0.22
WSX1 1855887 Hs.132781 3259 -0.01 0.34 0.12 0.3
HIST1H1A 1872543 Hs.150206 2523 0.07 0.34 -0.17 0.14
TFAP2B 363144 Hs.33102 2510 0.05 0.34 0.67 0.35
TRIM31 509760 Hs.91096 2753 0.06 0.34 -0.08 0.2
FLJ00166 713191 Hs.43213 3134 0.08 0.34 0 0.22
CDK5R1 757873 Hs.93597 2965 -0.12 0.34 -0.22 0.15
PPP3CA 796730 Hs.272458 2605 -0.07 0.34 -0.36 0.16
PMS2L4 161373 Hs.278468 2534 -0.14 0.35 -0.21 0.22
DLGAP1 1758491 Hs.75814 2143 0.02 0.35 -0.24 0.2
ESTs 177884 Hs.14613 2054 0.01 0.35 -0.22 0.25
NRL 2364249 Hs.89606 2300 -0.04 0.35 -0.09 0.14
RAB36 281489 Hs.38772 3143 -0.08 0.35 0 0.12
RPC8 323603 Hs.353192 2367 -0.06 0.35 -0.33 0.24
ZNF177 33294 Hs.172979 2988 0.01 0.35 -0.21 0.25
LY6G5C 448136 Hs.246845 3591 -0.02 0.35 -0.44 0.28
RAD17 586844 Hs.16184 3797 -0.01 0.35 0.12 0.15
LOC253039 1033388 Hs.41181 3612 -0.02 0.36 0.31 0.08
IMPDH2 1582050 Hs.75432 2709 -0.01 0.36 -0.08 0.18
PRMT3 2074202 Hs.152337 2042 0.07 0.36 -0.06 0.21
FZD6 214916 Hs.114218 3884 0.03 0.36 0.02 0.26
AP3B2 47510 Hs.21022 2350 0.03 0.36 -0.23 0.31
NF2 769716 Hs.902 2887 -0.08 0.36 -0.11 0.31
SCP2 855395 Hs.75760 3218 -0.12 0.36 -0.1 0.19
COL8A1 1472775 Hs.114599 4178 -0.06 0.37 0.05 0.18
AKAP4 1643144 Hs.97633 2557 -0.03 0.37 -0.07 0.15BMC Genomics 2004, 5:55 http://www.biomedcentral.com/1471-2164/5/55
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"Leave-one-out cross-validations" were used to estimate
the error [33,34]. In each validation experiment one array
was left out. The remaining 383 arrays were used to iden-
tify endogenous reference genes using the same parame-
ters used for the original analysis (test/reference ratios < 2
SD in at least 95% of the experiments and average inten-
sity > 2,000 in both channels). The median Log2 ratio of the
endogenous reference gene in the left out array was then
compared with the "real" normalization factor consisting
of the median Log2 ratio for all genes in that array supposed
to approximate a balanced expression of test and reference
genes for that array. This procedure was repeated for each
array 384 times. Only in 3 arrays out of 384 (2.3%) were
found errors in endogenous reference gene selection
(errors were considered median Log2 ratio of endogenous
reference genes in the left out array > 2 standard devia-
tions apart from the "real" normalization factor in the
same array (which is zero for normalized arrays).
The expression of each candidate endogenous reference
gene identified in this study was then compared with
available information about the expression of the same
genes in 12 normal human tissues reported by the
Affymetrix HG-U95A-E probe sets http://nci
array.nci.nih.gov/cards/index.html. We found a good cor-
relation between the expression patterns observed by us
and that reported by the Affymetrix GeenChip array (data
not shown). In addition, a cluster of endogenous refer-
ence genes suggested by Applied Biosystems for standard-
ization during qRT-PCR was analyzed by evaluating the
SD of their Log2 ratios across the 384 arrays. As data indi-
cated in Table 2, although some genes (bold) demon-
strated mean SD Log2 ratios comparable to that of the
endogenous reference genes identified in this study, the
corresponding percentage of the arrays in which Log2 ratios
were within 2 SD from zero ranged between 0.68–0.85
which is significantly lower than the frequency in which
the same parameter fell for the 69 candidate house keep-
ing genes identified here (>95%). In addition, we looked
at the variation in our arrays of genes classically used as
endogenous reference genes including: ribosomal protein
L32, HRPT, β-actin and tubulin-α3. In all cases the mean
SD of Log2Ratio was relatively larger than for the endog-
enous reference genes identified in Table 1 with the fol-
lowing respective values: 0.88 for Ribosomal protein L32,
1.13 for HRPT, 1.32 for β-actin and 1.42 for laminin-α3.
Interestingly, however, the mean intensities were rela-
tively higher for all of these genes compared with the ones
identified in this study (7,369; 12,778, 43,794 and 42,241
for the four genes respectively) suggesting that these genes
are expressed probably at higher concentrations in tissue
and, therefore, although relatively variable in expression
in different tissues, they have been a useful marker of RNA
abundance when only rough estimates are required like,
for instance, for Northern Blotting.
Test gene expression estimates according to house-
keeping gene selection: the transcriptome array
To validate the usefulness of candidate endogenous refer-
ence genes in large sample populations we developed a
new tool that we are planning to use in the future for val-
idation of gene expression across extensive data sets. This
tool displays cDNA libraries originated from different tis-
sues or cell lines individually spotted on a solid surface.
The principle of this technology is similar to RNA dot blot
which uses RNA isolated from samples and transferred to
membrane making, therefore, the transcriptome array a
high-density dot blot. The labeled DNA probe of interest
is hybridized to the immobilized complementary strain of
mRNA. A reference gene hybridization will carried out
simultaneously to estimate the relative expression of the
gene of interest compared with the reference gene. The
new tool we describe here, termed transcriptome array,
utilizes cDNA generated from source mRNA for target
immobilization to improve the stability of the immobi-
lized targets and differentially fluorescence-labeled test
and reference probes (RNA or double strained DNA) then
can co-hybridize on to the same spots. Using a validated
Unknown 1671546 3386 0.03 0.37 1 0.42
TCF8 178463 Hs.232068 2726 -0.04 0.37 -0.01 0.06
TNP2 1839038 Hs.2748 2737 0.08 0.37 0.11 0.24
PIWIL1 2329739 Hs.194712 2573 -0.08 0.37 -0.14 0.22
DBCCR1 47037 Hs.6090 2481 -0.01 0.37 -0.18 0.24
SLC21A3 289706 Hs.46440 2708 0 0.38 -0.11 0.27
ESTs 35105 Hs.403854 3126 0.03 0.38 0.23 0.18
cDNA FLJ34400 fis 511835 Hs.380035 3058 0 0.38 0.02 0.37
CNTN1 51640 Hs.143434 2479 -0.05 0.38 -0.11 0.3
TFCP2 843067 Hs.154970 3728 -0.06 0.38 0.16 0.34
C17orf35 510032 Hs.15196 2778 -0.02 0.39 0.09 0.28
AFAP 488062 Hs.80306 3142 0 0.42 0.12 0.15
MTP 731054 Hs.195799 2764 -0.01 0.42 -0.09 0.4
Table 1 (Continued)BMC Genomics 2004, 5:55 http://www.biomedcentral.com/1471-2164/5/55
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RNA amplification technology [30], large quantity of pure
amplified RNA with proportional representation of
source mRNA species could be generated from which
cDNA could be obtained through a reverse transcription
reaction. Because of the minimum amount of cDNA used
for fabricating each transcriptome array (<5 nano gram
cDNA/spot) and the size of spots (100 um), the expres-
sion of a large number of genes can be theoretically ana-
lyzed on thousands of different samples simultaneously.
Since the amount of cDNA spotted may vary according to
the quality of the starting material and the efficiency of
RNA preparation for each sample, absolute estimation of
fluorescence from the hybridized probe is not informative
of the expression of the given gene in each sample. There-
fore, a reference system is necessary so that comparative
expression of the test gene can be presented proportional
to that of a consistently expressed gene across all samples.
Therefore, interpretation of data derived from the tran-
scriptome array relies on endogenous reference gene
normalization.
To test the usefulness of various endogenous reference
gene we resorted to the well characterized expression of
the melanocytic lineage-specific gene gp100/Pmel17 [31]
that is expressed exclusively though heterogeneously in
cells of melanocytic lineage [35,36]. The assumption of
this experiment was that in spite of its heterogeneity of
expression in samples of melanocytic origin, overall the
expression of gp100 should be higher in meloanocytic
compared with non melanocytic samples with a high
degree of significance. Rho-C has been associated with the
metastatization process in melanoma but its specificity for
melanocytic lineage is unknown [37]. The differentiation
control element DICE is found in the 3'-UTR of numerous
eukaryotic mRNAs and there is no solid association
between its pattern of expression and specific physio-
pathological or developmental conditions [38]. There-
fore, we compared the expression profile of these three
genes in 829 cDNA libraries that included 106 melanoma
cell lines, 127 melanoma metastases, 2 benign nevi (total
of 235 melanocytic samples) and 593 miscellaneous sam-
ples containing a predominance of primary esophageal,
renal and colon cancers paired with normal tissues from
the same organ and a large number of circulating mono-
nuclear cells. In addition, samples from most other nor-
mal and cancerous tissues were included although in
Table 2
Gene Name Image ID Description Mean Int Mean logR SD logR % of arrays
NKTR 712460 NK-tumor recognition protein=cy 7319.55 0.62 0.79 0.52
NKTR 712460 NK-tumor recognition protein=cy 3048.28 0.19 0.43 0.84
NKTR 712460 NK-tumor recognition protein=cy 8637.15 0.99 0.99 0.53
NKTR 2064497 natural killer-tumor recognitio 959.97 0.72 0.85 0.7
PPIC 882459 peptidylprolyl isomerase C (cyc 5034.82 2.11 1.45 0.44
PPIB 756600 peptidylprolyl isomerase B (cyc 6606.09 1.08 1.04 0.39
PPIL2 450661 peptidylprolyl isomerase (cyclo 3035.17 0.16 0.4 0.85
PPIL2 2017652 peptidylprolyl isomerase (cyclo 850.93 0.23 0.48 0.76
PPIG 809621 peptidyl-prolyl isomerase G (cy 3991.93 0.28 0.53 0.67
PPID 884500 peptidylprolyl isomerase D (cyc 5805.51 0.33 0.57 0.66
PPID 71154 peptidylprolyl isomerase D (cyc 5652.12 0.27 0.52 0.63
PPIH 767277 peptidyl prolyl isomerase H (cy 3277.26 0.28 0.53 0.73
PPIF 758343 peptidylprolyl isomerase F (cyc 15900.53 3.18 1.78 0.13
CYP2J2 454580 cytochrome P450, family 2, subf 2302.76 0.71 0.84 0.65
PPIA 2580290 peptidylprolyl isomerase A (cyc 25478.36 1.32 1.15 0.36
PPIA 1570861 peptidylprolyl isomerase A (cyc 5028.34 0.76 0.87 0.46
GAPD 50117 glyceraldehyde-3-phosphate dehy 38011.52 1.66 1.29 0.4
GAPD 530934 glyceraldehyde-3-phosphate dehy 10526.82 1.14 1.07 0.37
GAPD 530868 glyceraldehyde-3-phosphate dehy 5052.59 0.81 0.9 0.25
GAPD 755641 glyceraldehyde-3-phosphate dehy 1693.23 0.17 0.42 0.84
PGK1 949939 Phosphoglycerate kinase 1 4452.92 0.16 0.4 0.85
B2M 878798 beta-2-microglobulin 34211.05 2.08 1.44 0.43
AMBP 2063390 alpha-1-microglobulin/bikunin p 1813.96 0.15 0.39 0.86
GUSB 2273001 glucuronidase, beta 6205.14 0.81 0.9 0.41
GUSB 276449 glucuronidase, beta 2241.73 0.22 0.47 0.68
HPRT1 280507 hypoxanthine phosphoribosyltran 12778.31 1.29 1.14 0.35
TBP 280735 TFIID=TATA box binding protein 4065.4 0.24 0.49 0.73
TFR2 461750 transferrin receptor 2 2700.22 0.19 0.44 0.84
TFR2 2408681 transferrin receptor 2 2958.88 0.21 0.46 0.82BMC Genomics 2004, 5:55 http://www.biomedcentral.com/1471-2164/5/55
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smaller number (complete list of samples available upon
request).
As endogenous reference genes we chose β-Actin and new
candidate genes identified by this study (see previous sec-
tion). The test genes (gp100, Rho-C and DICE) were sep-
arately hybridized to the transcriptome array. Each gene
labeled with Cy3 was co-hybridized with individual
endogenous reference genes labeled with Cy5. We then
compared Log2 Cy5 / Cy3 ratios between melanocytic and
non-melanocytic tissues. gp100 was, as expected,
expressed more in melanocytic lesions with high degree of
significance no matter what gp100 / endogenous refer-
ence gene combination was used. The range of signifi-
cance, however, varied extensively depending upon the
gp100 / endogenous reference gene combination. This
difference was considered representative of the ability of
different endogenous reference genes to normalize for tis-
sue-specific gene expression patterns (Figure 1). In details,
all endogenous reference genes could segregate melano-
cytic from non melanocytic lesions with a high degree of
significance (Figure 2; unpaired two sample t test p2-val-
ues ranged from 6 × 10-8 to 3 × 10-36). There was, however,
a big range in the discriminatory capacity among endog-
enous reference genes with NEDD8, RAB3 and FZD6 pro-
viding the highest predictive value (t test p2-value = 3 × 10-
36, 1 × 10-32 and 1 × 10-21 respectively) and β-actin being
one of the least reliable (t test p2-value = 1 × 10-8).
The large variation in the results obtained using different
endogenous reference genes to normalize gp100 expres-
sion could have been due to a higher stability of the
expression of some genes across all samples or to a differ-
ential expression of the endogenous reference genes
themselves in melanocytic lesion. In the latter case, the
better results obtained could be coincidental and not use-
ful in other experimental situations. We, therefore, tested
whether pooling results obtained with all endogenous ref-
erence genes independently of each predictive value in
this controlled experimental situation could yield results
as informative about gp100 pattern of expression as those
obtainable with individual endogenous reference genes,
particularly those that provided the best prediction. The
advantage of this strategy is that it does not depend on
previous knowledge of gene expression patterns for the
selection of individual endogenous reference genes not
applicable in conditions, in which the suitability of a gene
for a given experimental situation is, contrary to gp100, is
unknown. Thus, we compared the predictive value of the
average of gp100 / endogenous reference gene Log2 ratios
obtained with all endogenous reference genes and those
obtained using the genes that provided the best five or the
best three results (Figure 2). The use of pooled informa-
tion from various endogenous reference genes appeared
to stabilize the non-melanocytic Log2 ratios gp100 / endog-
enous reference. In fact, the SD of theLog2 ratios gp100 /
endogenous reference among non-melanocytic samples
derived by pooling endogenous reference gene results
were significantly lower than the SD obtainable with any
individual endogenous reference gene (F-test). The basis
for this test was that non-melanocytic lesions uniformly
should not express gp100 and, therefore, the Log2 ratios for
any gp100 / endogenous reference gene combination
should be constant resulting in very low SD. SD for non-
melanocytic lesions were much lower using pooled
endogenous reference genes for the normalization (Figure
2) and this was true at extreme levels of significance (F-test
value for SD when all endogenous reference genes were
used for normalization compared with individual endog-
enous reference were 0, 1.5 × 10-9, 0, 5.6 × 10-7, 9.0 × 10-
5, 0, 0, 0 and 0 for NEDD8, RAB3, FZD6, AFAP, COL8A,
SNRPD, HIRIP5, β-actin and GPLD1 respectively). Similar
results were obtained when results from the best 5 and
best 3 endogenous reference genes were pooled together.
In addition, even if pooling data together did not provide
the highest level of discrimination compared to the best
results obtained with selected individual endogenous ref-
erence genes, the capacity of pooled data sets to discrimi-
nate gp100 expression between melanocytic and non
melanocytic samples was still very high (2 × 10-22; 4 × 10-
29 and 1 × 10-34 respectively when all, the best 5 or the best
3 endogenous reference gene results were pooled
together). Interestingly, different endogenous reference
genes provided not only different levels of discrimination
but also provided different estimates of gp100 expression
in melanocytic lesions with gp100 / endogenous reference
gene  Log2  ratio above (NEED8, RAB3, FZD6, AFAP,
SNRPD3, HIRIP5, GPLD1) or below (COL8A1, β-actin) 0
(Bottom graph, Figure 2). This, of course, has no impact
on the ability to characterize patterns of expression of dif-
ferent genes in different tissues but rather suggests that the
latter group of endogenous reference genes is expressed at
higher copy number, therefore, biasing the data toward its
own fluorescence channel. Simple adjustment in probe
concentration could easily solve this problem.
We then analyzed the expression of Rho-C and DICE
whose pattern of expression in the transcriptome array
cannot be predicted based on available information save
for the notion that of the expression of Rho-C is related to
the metastatic process of melanoma [37]. The pattern of
Rho-C was characterized with all the endogenous
reference genes and representative information is pre-
sented in Figure 3. Most endogenous reference genes
yielded a pattern suggestive of a preferential expression of
Rho-C in melanoma metastases. In addition, averages of
Rho-C / endogenous reference gene Log2ratios demon-
strated clearly a specific expression of this gene in
melanoma metastases. This pattern was not necessarily
specific for melanoma as the other cancerous tissuesBMC Genomics 2004, 5:55 http://www.biomedcentral.com/1471-2164/5/55
Page 8 of 17
(page number not for citation purposes)
spotted in the transcriptome array were obtained from pri-
mary lesions. Thus, it is possible that the preferential
expression in melanoma metastases was due to the meta-
static process rather than the melanocytic lineage. Inter-
estingly, the melanoma cell line Mel-A375 did not
constitutively express Rho-C as previously observed by
Clark et al. [37]. In addition, none of the melanoma cell
lines mostly derived from melanoma metastases demon-
strated expression of Rho-C. This information suggests
that Rho-C may be involved in the natural metastatic
Comparison of gp100 expression normalized by different endogenous reference genes Figure 1
Comparison of gp100 expression normalized by different endogenous reference genes. Candidate endogenous reference genes 
were selected among those in Table 1. The gp100 probe (Cy3) was co-hybridized with one endogenous reference gene probe 
(Cy5) at the time to the transcriptome array. The transcriptome array included 235 cDNA libraries derived from samples of 
melanocytic lineage (maroon bar) and 594 cDNA libraries from samples of non melanocytic lineage (green bar). Melanocytic 
samples consisting in the overwhelming majority of melanoma metastases or melanoma cell lines while non-melanocytic librar-
ies included a large collection of esophageal, kidney, colon and other cancers and several normal tissues or circulating mononu-
clear cells. The complete list of samples is available upon request. The expression of gp100 normalized with different 
endogenous reference genes was compared by unpaired two-tailed student t test and the endogenous reference genes were 
ranked according to the level of significance in their ability to discriminate between melanocytic and non-melanocytic lesions 
(data presented as the Log10 p2-value (shown in the boxes associated with individual graphs; for details see Figure 2). The distri-
bution of the Log2 ratios for each individual cDNA library is shown for each gp100 / endogenous reference gene combination. In 
addition, results compiled using the average of the Log2 ratios for all the endogenous reference genes, the 5 and the 3 with the 
lowest p2-value are presented (orange bar graphs).BMC Genomics 2004, 5:55 http://www.biomedcentral.com/1471-2164/5/55
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process in vivo but is not constitutively expressed in vitro.
Finally, DICE did not demonstrate any specificity of
expression and appeared variably expressed in all speci-
mens independently of the endogenous reference gene
used for normalization.
Validation of data by protein analysis and quantitative 
real-time PCR (qRT-PCR)
We tested whether gp100 / endogenous reference gene Log2
ratios correlated with gp100 protein expression level as
measured by intra-cellular FACS analysis (Figure 4). The
gp100 / endogenous reference gene Log2  ratios were
derived from the transcriptome arrays while protein
expression was based on previous characterizations of the
same cell lines [35,39]. Overall, a good correlation (Pear-
son's correlation) was noted for gp100 values normalized
with most endogenous reference genes. However, with the
exception of NEDD8, the best correlation was obtained
when pooled information was used from the best 5 and 3
candidate endogenous reference genes as defined before.
Expression of gp100 by melanocytic and non melanocytic lesions normalized with different endogenous reference genes Figure 2
Expression of gp100 by melanocytic and non melanocytic lesions normalized with different endogenous reference genes. Aver-
age gp100 / endogenous reference gene Log2 ratios for melanocytic and non-melanocytic lesions are shown together with the 
standard deviation (SD) standard error from the mean (SEM) and the Log10 of the t-test p2-values when melanocytic and non-
melanocytic lesions were compared. Also data derived from mathematically averaging the results obtained with all the endog-
enous reference genes, the ones yielding the best 5 individual p2-values and the best three are shown. The same data are pre-
sented visually in the bar graph below; in black are data derived with individual endogenous reference gene normalizations, in 
orange data derived by averaging results from different endogenous reference genes. Filled bares portrait data from melano-
cytic lesions, empty bars from non-melanocytic lesions.BMC Genomics 2004, 5:55 http://www.biomedcentral.com/1471-2164/5/55
Page 10 of 17
(page number not for citation purposes)
Interestingly, RAB3 that scored very high as a predictor of
gp100 transcriptional expression in melanocytic lesions
and β-actin provided the worst correlation with protein
expression. This data suggest that, although different
endogenous reference genes may yield better predictive
value than others in large data sets, it is likely that their
reliability varies in different conditions and possibly the
best results can be obtained by pooling information from
several of them.
We also tested by quantitative real-time PCR (qRT-PCR)
the discriminatory capacity of endogenous reference
genes in samples with known patterns of expression of
gp100. We selected 6 previously characterized [35,36]
melanoma cell lines four of which were known to express
(MEL-553B, MEL-1317, MEL-526, MEL-1102) and two
known not to express (MEL-836, MEL-1195) gp100 at the
transcriptional and protein level (Figure 5) [36,39]. In
addition, 4 fine needle aspirate (FNA) samples from
Relative expression of gp100, Rho-C and DICE in melanocytic and non-melanocytic samples Figure 3
Relative expression of gp100, Rho-C and DICE in melanocytic and non-melanocytic samples. Test samples (Cy3) and endog-
enous reference genes (Cy5) were hybridized to the transcriptome array as described in Figure 1. Test gene / endogenous ref-
erence gene Log2 ratios are displayed as a bar graph for NEED8, β-actin and for the averages of test / endogenous reference 
geneLog2 ratios when the three endogenous reference genes with the best discriminating power in separating gp100 expression 
between melanocytic (maroon bar) and non-melanocytic (green bar) lesions (NEDD8, RAB3 and FZD6) were used. Samples 
derived from melanoma metastases are shown by the orange bar. In the boxes the Log10 p2-value of significance of differences 
between relevant samples (se text) are shown; ns = non significant).BMC Genomics 2004, 5:55 http://www.biomedcentral.com/1471-2164/5/55
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melanoma metastases expressing gp100 [40] and a series
of tumors (2 renal cell, 2 esophageal one gastric carcino-
mas and HELA cells line) known not to express gp100
were tested. Absolute expression of gp100 was measured
and although the lesions supposed to be gp100 expressing
appeared more positive than those supposed to be gp100
negative there was no absolute demarcation among the
two groups (Figure 5a). A better differentiation between
positive and negative lesions could be obtained when the
various endogenous reference genes were used for the
analysis or the combined values from all of them (Figure
5b).
Discussion
Although the concept of endogenous reference genes is
appealing it may be unrealistic to expect that a gene could
be equally expressed in all eukaryotic cells in all physio-
pathological conditions. Thus, the endogenous reference
gene concept can only approximate such ideal biological
behavior. In fact, numerous studies noted that the
Correlation of gp100 expression estimated obtained by intracellular FACS analysis and by gene profiling with the transcriptome  array Figure 4
Correlation of gp100 expression estimated obtained by intracellular FACS analysis and by gene profiling with the transcriptome 
array. Cell lines with different level of gp100 expression by intra-cellular FACS analysis using the gp100-specific mAb HMB45 
[35] were used for the analysis. The compiled information from the transcriptome array in which cDNAs from each cell line 
was spotted are shown. The Cy5/Cy3 (endogenous reference gene / gp100) Log2 ratios are shown for each endogenous refer-
ence gene evaluated. In addition, ratios derived by using the data from all the endogenous reference genes, the best 5 and best 
3 according to figure 2 are also presented. Pearson's correlation for the data set is shown for each endogenous reference gene 
and the same information is summarized graphically at the bottom of the figure. MEF = mean equivalent of fluorescence [35].BMC Genomics 2004, 5:55 http://www.biomedcentral.com/1471-2164/5/55
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expression of the ostensible endogenous reference genes
varies according to distinct physio-pathological situations
and can be affected by experimental manipulation
[2,20,24,26,27,41]. For instance, the levels of expression
of GAPDH, cyclophilin and β-actin fluctuate in different
tissues, disease stage and are affected by cell behavior like
proliferation [6,15,18,20,42]. In addition, endogenous
reference genes expression varies markedly in cancer com-
pared to normal tissue [17,26,41] suggesting that onco-
genesis may influence their expression [25].
In this study, therefore, we looked for relative stable
endogenous reference gene challenging a 17,000 cDNA
clone data base against approximately 400 specimens that
included a broad variety of normal and neoplastic tissues
as well as cell lines. Indeed, few previously unnamed
Absolute and normalized expression of gp100 based on qRT-PCR Figure 5
Absolute and normalized expression of gp100 based on qRT-PCR. Four melanoma cell lines expressing gp100 (MEL-553B, MEL 
1317, MEL 526 and MEL-1102) and 2 not expressing gp100 (MEL-836 and MEL-1195) protein by FACS analysis [35] (maroon 
horizontal bar) were tested for gp100 expression by qRT-PCR as previously described [40]. In addition four fine need aspirates 
of melanoma metastases all expressing GP100 by immunohistochemistry (orange horizontal bars) and two renal cell, two 
esophageal and one gastric cancer specimens all not expressing gp100 (green horizontal bar) were tested. Similarly the gp100 
not expressing HeLa cell line was tested. Absolute gp100 copy number is shown in (a); normalized expression of gp100 is 
shown using the average of all endogenous reference gene results (b). The protein expression for the melanoma cell lines is 
presented as mean equivalent of fluorescence (MEF) [35] as well as immunohistochemical evaluation while the expression by 
FNA is shown in (c) based on immunohistochemical (HIC) evaluation as previously described [46]. Absolute copy numbers of 
gp100 estimated by qRT-PCR are also shown.BMC Genomics 2004, 5:55 http://www.biomedcentral.com/1471-2164/5/55
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genes approximated the ideal endogenous reference gene
by being expressed consistently in more than 95% of the
specimens analyzed within a variance that was barely and
insignificantly different from what could be expected
from intrinsic experimental fluctuation (Table 1). In fact,
the threshold that we selected based on the variance
observed by periodically repeating identical experiments
was consistent with criteria suggested by others [43] who
claimed that genes with fold changes greater than 1.5 can
be classified as differentially expressed at ~95% confi-
dence interval. This is consistent to our selection criterion
that contained endogenous reference genes within a 1.46
fold maximal variation. Although these genes have not
been proposed before as candidate endogenous reference
genes, analysis of available data bases suggested that they
are relatively stably expressed in various normal tissues
(i.e. Affymetrix HG-U95A-E probe sets). Selection of these
candidate endogenous reference genes provided useful
information when the expression of a lineage specific
gene such as gp100 was compared between relevant and
irrelevant samples. In addition, gp100 expression normal-
ized according to some of the new endogenous reference
genes more closely aligned to lineage specificity than nor-
malization performed using β-actin.
This data, however, confirm that there is no such thing as
a perfect endogenous reference gene. Although some
endogenous reference genes demonstrated high power of
discrimination their ranking was dictated by previous
knowledge of the expected experimental results (gp100
being melanocytic lineage specific). However, gene
expression analysis is done to determine such specificity
and in most cases no previous knowledge of tissue specif-
icity is truly available. One may argue that, in spite of the
extreme variability in normalization power demonstrated
by various endogenous reference genes, still significant
differences could extracted between the melanocytic and
non-melanocytic samples no matter what endogenous
reference genes were used. This statement is correct in this
experimental situation where hundreds of samples could
be compared with the transcriptome array. However, in
cases when only few samples are analyzed the difference
in discriminatory capacity becomes critical. For instance,
when randomly selected gp100 / endogenous reference
gene Log2 ratios from 10 melanoma metastases were com-
pared with those from 10 kidney specimens only NEDD8,
RAb3, FZD6, AFAP, COL8, SNRPD and pooled endog-
enous reference gene-based normalizations yielded signif-
icant differences between the two groups while non
significant values were obtained for normalizations based
on HIRIP5, β-actin and GPLD1.
The lowest limit of detection in the transcriptome array of
specific probes in term of copy numbers is currently under
investigation. Decreasing concentrations of β-actin alone
printed the array spots as internal controls suggest that the
detection range is from 30 ng / spot to 3 pg / spot when
standard fluorescent intensity range parameters are
applied. The higher limit of detection before saturation
can be easily adjusted to avoid under estimates of highly
expressed genes, therefore, increasing the dynamic range
of detection. This is achieved by adjusting the fluorescent
intensity right below the saturation for both channel and
subsequently calculating the abundance of reference gene
expression using serially diluted internal control spots as
standard curve. With few exceptions, the expression of
most genes can be estimated with relative accuracy using
this semi-quantitative approach.
Since in most cases endogenous reference genes are
selected based on previous knowledge of their usefulness
for a particular experimental situations, it is likely that the
best consistency could be achieved in such circumstances
when averages of several endogenous reference gene
normalizations are used. This may represent a reasonable
solution particularly if a cocktail of endogenous reference
genes identically labeled could be used as reference within
a single experiment. We are presently testing various com-
binations of lineage specific genes and pools of endog-
enous reference genes for hybridization to the
transcriptome array and for qRT-PCR. Such attempts,
however, have been quite disappointing so far as results
obtained using mixture of endogenous reference genes do
not yield information comparable to that achievable
when results obtained with the same endogenous refer-
ence genes used individually are pooled together. This is
possibly due to imbalanced density of various endog-
enous reference genes in different samples with predomi-
nant effects of some over others. Therefore, extensive work
in the future will be aimed at equilibrating the interac-
tions among endogenous reference genes in various
experimental conditions to test whether mixtures of them
could be used in multiplex for normalization of large
expression analysis studies.
Conclusions
Our observations, together with previous work by others
indicate that much caution should be taken when using
endogenous reference to normalize the expression of test
genes. It is likely that previous analyses based on single
endogenous reference genes might have been strongly
biased by the individual selections and the interpretation
of the results should looked at with caution. In particular,
this study suggests that even when the most stably
expressed genes in array experiments are used as endog-
enous reference genes, significant variation in test gene
expression estimates may occur and the best normaliza-
tion is achieved when data from several endogenous refer-
ence genes are pooled together to minimize minimal but
significant variation among samples. We are presentlyBMC Genomics 2004, 5:55 http://www.biomedcentral.com/1471-2164/5/55
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optimizing strategies for the preparation of endogenous
reference gene mixtures that could yield information com-
parable to that of data pooled from individual endog-
enous reference gene normalizations.
Methods
The list of samples used for cDNA microarray hybridiza-
tion or for preparation of the transcriptome array is avail-
able upon request. Most melanoma and renal carcinoma
cell lines were generated at the Surgery Branch, National
Cancer Institute (NCI), National Institutes of Health
(NIH), Bethesda, MD and maintained in RPMI (Biosource
International, Camarillo, CA) supplemented with 10%
fetal calf serum (Biosource). Cell lines were harvested by
Trypsin /Versene (Biosource) digestion. PBMC were col-
lected by leukapheresis from six unrelated normal donors
in the Department of Transfusion Medicine, Clinical
Center, NIH and purified by Ficoll gradient separation.
Surgically removed tumor tissues were collected from the
Tissue Network (Philadelphia, PA), Surgery Branch and
CPSB specimen bank, NCI, (Bethesda, MD). Fine needle
aspiration (FNA) biopsies were obtained from patients
with metastatic melanoma referred to the Surgery Branch,
NCI for immunotherapy. Total RNA was isolated using
Qiagen RNeasy kit and its quality and quantity was
estimated using Agilent Bioanalyzer 2000 (Agilent Tech-
nologies, Palo Alto, CA).
Target preparation for cDNA microarray hybridization
Total RNA extracted from test and reference samples was
transcribed  in vitro into anti-sense RNA (aRNA) and
reverse-transcribed into fluorescence labeled cDNA for
hybridization to 17,000 gene cDNA-based microarrays
[30,44]. Pooled PBMC were used to prepare reference
aRNA to be co-hybridized in all experiments with test
aRNA. cDNA targets were labeled with Cy3 (green) for ref-
erence material and Cy5 (red) for test material with the
exception of reciprocal experiments.
cDNA Microarrays
cDNA (UniGene cluster) microarrays were printed at the
Immunogenetics Section, DTM, CC, NIH with a configu-
ration of 32 × 24 × 23 containing 17,500 elements. Clones
used for printing were selected from the Research Genetics
RG_HsKG_031901 8 k clone set and the 9k
RG_Hs_seq_ver_070700 40 k clone set. The 17,500 spots
included 12,072 uniquely named genes, 875 duplicate
genes and about 4,000 expression sequence tags. For a
complete list of genes included in the Hs-CCDTM-17.5k-
1px printing please visit our web site at http://nci
array.nci.nih.gov/gal_files/index.shtml.
Transcriptome array
A collection of aRNA-based libraries was prepared from
960 frozen tissue samples or cell lines and individual
aRNAs were reverse transcribed into cDNA in the presence
of 1 µl of dN6 primer (8 µg/µl), 6 µl of first strand buffer,
3 µl of 10 mM dNTP, 3 ul of 50 mM dTT, 1.5 µl of Rnasin
and 10 µl of aRNA (6–12 ug) with addition of 3 µl of
Superscript II (BRL) in 5.5 µl volume after heating to
65°C for 5 minutes. Reactions were carried out in 96-well
plates at 42°C for 90 minutes followed with addition of 1
µl Rnase H and heating for 20 min at 37°C. cDNA were
further purified by utilizing CentriCept gelfitration plates
to remove non incorporated primer and dNTP. Purified
cDNA were transferred to 384-well plates and dried by
speedvac. Samples were re-suspended in 13 µl of 3 × SSC
followed by shaking at 3,000 rpm for 15 min. Reconsti-
tuted cDNA libraries from individual samples and spiked
reference gene at different concentration were printed on
to poly-L-lysine coated glass slides at the concentration of
0.5–1 µg/µl using the OmniGrid (GeneMachine. San Car-
los, CA) printer and Telechem printing pins (TeleChem
International, Inc. Sunnyvale, CA). Each 100 µm diameter
spot was duplicated at a 250 µm distance. After complete
exsiccation, slides were post-processed as described at
http://nciarray.nci.nih.gov/reference/
Post_Processing.html.
Probe design Transcriptome array hybridization 
experiments
Specific PCR primers for the amplification of each gene
probe were designed using Primer 3 program http://mol
bio.info.nih.gov/molbio/analysis.htm. In order to gener-
ate single strand fluorescence labeled cDNA for
hybridization, modified specific 5' primers with an exten-
sion of the T7 promoter region were used for PCR ampli-
fication. Double strand PCR fragments (300–800 bp)
were used as template for in vitro transcription to generate
single stranded mRNA. 3 µg of amplified RNA were then
reverse transcribed into cDNA in present of 4 µl of first
strand buffer, 1 µl dN6 primer (8µg/µl; Boehringer Man-
nheim), 2 µl 10 X low T-dNTP (5 mM A, C and GTP, 2 mM
dTTP), 2 µl Cy-dUTP (1 mM, Cy3 or Cy5), 2 µl 0.1 M DTT,
1 µl RNasin, 3 µg amplified mRNA in 8 µl DEPC H2O.
After heating to 65°C for 5 minutes and cooling to 42°C,
2 µl of SSII was added and the labeling reaction was car-
ried out at 42°C for 90 min. Probe purification and
hybridization were performed as previously described
[30,44].
Quantitative real-time polymerase chain reaction (RT-
PCR)
Primer and probe sets from each candidate genes were
designed using the Primer Express 2.0 program (Applied
Biosystems, Foster City, CA) and synthesized by Bio-
Source. Taqman probes were labeled at the 5' end with the
reporter dye molecule 6-carboxy-fluorescein (FAM; emis-
sion λmax = 518 nm) and at the 3' end with the quencher
dye molecule 6-carboxytetramethyl-rhodamine (TAMRA;BMC Genomics 2004, 5:55 http://www.biomedcentral.com/1471-2164/5/55
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emission λmax = 582 nm). Total RNA was used for gene
expression validation. Measurement of gene expression
was performed using the ABI 7900HT sequence detection
system (Perkin Elmer, Foster City, CA) as previously
described [40,45]. Messenger RNA from test samples were
reverse transcribed into cDNA in the presence of oligo dT
(12–18 mer). The qRT-PCR procedure was performed by
alternating 2 minute cycles at 50°C and 10 minute at
95°C. Forty cycles involving denaturation at 95°C for 15
seconds and annealing/extension at 60°C for 1 minute in
50 µl volume with 1 × TaqMan Master Mix (PerkinElmer).
Standard curves were generated for each gene with high
and accurate PCR amplification efficiency as determined
by the slope of the standard curves. Linear regression anal-
ysis of all standard curves documented in all cases an R
value ≥ 0.99. The sequence of primer sets and probes used
for each gene are shown in Table 3 with statistics for each
standard curve. Standard curve extrapolation of copy
number was performed for the gene of interest as well as
an endogenous reference gene for each sample. To correct
for concentration of starting material, normalization of
samples was performed by dividing the copies of the gene
of interest by copies of the reference gene as previously
described [40].
Authors' contributions
PJ validated the system combining high-throughput data
with gene-directed analysis by quantitative real-time PCR.
Table 3: Quantitative RT-PCR primers and probes
AFAP (+)-TGTCAAGTTAAACCACTAATGTGTTGGT Y = -3.105x + 43.726 R2 = 0.99
(-)-GGCATCCAAATTCTCCAAGAAA
FAM-TGCTGCCTCTCCTGAGTAGGGTGGGT-TAMRA
CDK5R1 (+)-TCCTACATGGGCAACGAGATC Y = -3.315x + 45.983 R2 = 0.99
(-)-CCAAAAGGCCTCCTTGCA
FAM -TACCCGCTCAAGCCCTTCCTGGTG -TAMRA
COL8A1 (+)-CCGAGCTAACCGCACCTTT Y = -3.143 x +43.294 R2 = 0.99
(-)-GTCTGCGGGTTGTAGTTCTGTCT
FAM -AGTGAAGTTTAACAAACTGCTGTATAACGG -TAMRA
FZD (+)-AGCCTCAAAGGTTCCACATCTC Y = -3.515 x + 47.092 R2 = 0.99
(-)-AGGTCACTTCCAGTGTAACACAAATT
FAM -TGAGAAAAGAGCAGGGAGGTGGTTGTCA -TAMRA
GPLD1-1 (+)-CAGATTGAAGATTTCACTGCATTTC Y = -3.653 x + 49.086 R2 = 0.99
(-)-CATCAAAATGCTCACCATGGA
FAM -TCTGCCCACCTCTCTCATGCTGAATCAC -TAMRA
GPLD1-2 (+)-CTTTTGCCTGTAGTAGTAAATTGCTTTTA Y = -3.168x + 46.599 R2 = 0.99
(-)-AACTGGCCATATAAC CAAAGGTGTT
FAM -TGAATGGTGTTTATTAAACCCTTATGGTCGATATTTCC-TAMRA
HIRIP5 (+)-GCTGCCCTAGTTCAATCATTACTCT Y = -3.160x + 43.313 R2 = 0.99
(-)-CGCCTTCTACCTCCGGAATAT
FAM – AAAAATGGAATTCAGAACATGCTGCA-TAMRA
HIST1HIA (+)-AGGCGTCCTCCGTGGAA Y = -3.143x + 43.294 R2 = 0.99
(-)-ATGCACCCGTTGCCTTAGTT
FAM – AGCCCGGCGCCTCAAAGGTG-TAMRA
NEDD8 (+)-TGACCGGAAAGGAGATTGAGA Y = -3.458x + 48.686 R2 = 0.99
(-)-CCACACGCTCCTTGATTCG
FAM – TGACATTGAACCTACAGACAAGGTGGA-TAMRA
PTH (+)-GCATAACCTGGGAAAACATCTGA Y = -3.063x + 45.215 R2 = 0.99
(-)-TGCACATCCTGCAGCTTCTT
FAM -TCGATGGAGAGAGTAGAATGGCTGC-TAMRA
RAB31 (+)-CCCCTGAAGGATGCTAAGGAA Y = -3.303x + 48.517 R2 = 0.99
(-)-AGCATTTTTTGCACTTGTCTCAAC
FAM – ACGCTGAATCCATAGGTGCCATC-TAMRA
SNRPD3 (+)-GGCACAGCTGGAGCAGGTAT Y = -3.177x + 47.200 R2 = 0.99
(-)-CTTCAGCATGTCAGGCAAAATC
FAM – ATCCGTGGCAGCAAAATCCGC -TAMRA
β-actin (+)-GGCACCCAGCACAATGAAG Y = -3.127x + 44.733 R2 = 0.99
(-)-GCCGATCCACACGGAGTACT
FAM-TCAAGATCATTGCTCCTCCTGAGCGC-TAMRA
gp100 (+)GGTTCCTTTTCCGTCACCCT Y = -3.282x + 45.987 R2 = 0.99
(-)CTCACCGGACGGCACAG
FAM-ACATTGTCCAGGGTATTGAAAGTGCCGAGAT-TAMRABMC Genomics 2004, 5:55 http://www.biomedcentral.com/1471-2164/5/55
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YZ performed statistical analysis. YN, MCP, DN, VM and
KS participated in the preparation and utilization of array
experiments used for the identification of stably expressed
genes. NH, HS and PRT provided a large library of samples
necessary for the development of the transcriptome array.
FMM supervise the project as principal investigator.
EW provided leadership for the development of cDNA
arrays, transcriptome array and for the overall conduct of
the experiments.
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